Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sarges

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Progress in Medicinal Chemistry|January 1, 1981
Hypoglycaemic drugsR Sarges
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|January 1, 1993
Aldose reductase inhibitors: recent developmentsR Sarges, P J Oates
Metabolism: Clinical and Experimental|April 1, 1986
Sorbinil: a member of the novel class of spirohydantoin aldose reductase inhibitorsR Sarges, M J Peterson
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1975
Stereospecific blockage of the alpha adrenergic receptor by substituted 1-aminotetralinesR Sarges, J W Constantine, W K McShane
Journal of Medicinal Chemistry|December 1, 1982
Spiro oxazolidinedione aldose reductase inhibitorsR C Schnur, R Sarges, M J Peterson
Medicinal Research Reviews|April 1, 1988
Medicinal chemistry of aldose reductase inhibitorsE R Larson, C A Lipinski, R Sarges
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1974
Blockade of heart 3H-norepinephrine up-take by 4-phenyl-1-aminotetralines: implications for the active conformation of imipramine-like drugsR Sarges, B K Koe, A Weissman, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonismO Nikodijević, R Sarges, J W Daly, et al.
Journal of Medicinal Chemistry|February 1, 1989
A novel class of "GABAergic" agents: 1-aryl-3-(aminoalkylidene)oxindolesR Sarges, H R Howard, B K Koe, et al.
Journal of Medicinal Chemistry|September 1, 1973
5,8-Disubstituted 1-aminotetralins. A class of compounds with a novel profile of central nervous system activityR Sarges, J R Tretter, S S Tenen, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Progress in Medicinal Chemistry|January 1, 1981
Hypoglycaemic drugsR Sarges
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|January 1, 1993
Aldose reductase inhibitors: recent developmentsR Sarges, P J Oates
Metabolism: Clinical and Experimental|April 1, 1986
Sorbinil: a member of the novel class of spirohydantoin aldose reductase inhibitorsR Sarges, M J Peterson
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1975
Stereospecific blockage of the alpha adrenergic receptor by substituted 1-aminotetralinesR Sarges, J W Constantine, W K McShane
Journal of Medicinal Chemistry|December 1, 1982
Spiro oxazolidinedione aldose reductase inhibitorsR C Schnur, R Sarges, M J Peterson
Medicinal Research Reviews|April 1, 1988
Medicinal chemistry of aldose reductase inhibitorsE R Larson, C A Lipinski, R Sarges
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1974
Blockade of heart 3H-norepinephrine up-take by 4-phenyl-1-aminotetralines: implications for the active conformation of imipramine-like drugsR Sarges, B K Koe, A Weissman, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonismO Nikodijević, R Sarges, J W Daly, et al.
Journal of Medicinal Chemistry|February 1, 1989
A novel class of "GABAergic" agents: 1-aryl-3-(aminoalkylidene)oxindolesR Sarges, H R Howard, B K Koe, et al.
Journal of Medicinal Chemistry|September 1, 1973
5,8-Disubstituted 1-aminotetralins. A class of compounds with a novel profile of central nervous system activityR Sarges, J R Tretter, S S Tenen, et al.
Pageof 3